Price Sensitive Information (PSI)

Information is related to securities which would if made public be likely to have a significant effect on the price of the securities. PSI (Price Sensitive Information) of Silva Pharmaceuticals Limited are described in this page.

PSI Half Year Ended 31 December, 2024
PSI of Unclaimed Dividend 2020-2021
PSI of Time Extension of IPO Proceeds
PSI 1st Quarter Ended September, 2024
PSI Year Ended 30 June, 2024
PSI 3rd Quarter Ended 31 March, 2024
Silva Pharmaceuticals PSI Principles
PSI Half Year Ended 31 December, 2023
PSI Time Extension of IPO Proceeds Utilization After AGM
PSI Time Extension of IPO Proceeds Utilization Before AGM
PSI 1st Quarter Ended 30 September, 2023
PSI Year Ended 30 June, 2023
PSI 3rd Quarter Ended 31 March, 2023
PSI Half Year ended 31 December, 2022
PSI 1st Quarter Ended 30 September, 2022
PSI Year Ended 30 June, 2022
PSI 3rd Quarter Ended 31 March, 2022
PSI Half Year Ended 31 December, 2021
PSI 1st Quarter Ended 30 September, 2021
PSI Year Ended 30 June, 2021
PSI 3rd Quarter Ended 31 March, 2021
PSI Half Year Ended 31 December, 2020
PSI 1st Quarter Ended 30 September, 2020
PSI Year ended 30 June, 2020
PSI 3rd Quarter Ended 31 March, 2020
PSI Half Yearly Ended 31 December, 2019
PSI 1st Quarter Ended 30 September, 2019
PSI of getting license from Department of Livestock Services (DLS)
PSI Year Ended 30 June, 2019
PSI 3rd Quarter Ended 31 March, 2019
PSI Half Yearly Ended 31 December, 2018
PSI 1st Quarter Ended 30 September, 2018

Investors

Price Sensitive Information (PSI)

Follow us on